DLT
Showing 1 - 25 of 6,592
Other Surgical Procedures Trial in Houston (Non-Video Double Lumen Tube (DLT), Fiberoptic Bronchoscopy (FOB), Video Double Lumen
Completed
- Other Surgical Procedures
- Non-Video Double Lumen Tube (DLT)
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 3, 2022
Thoracic Diseases, Thoracic Tumors, Thoracic Empyema Trial in Karachi (MaCintosh Laryngoscope (DL), McGrath Laryngoscope (VL))
Recruiting
- Thoracic Diseases
- +2 more
- MaCintosh Laryngoscope (DL)
- McGrath Laryngoscope (VL)
-
Karachi, Sindh, PakistanAga Khan University Hospital
Aug 9, 2023
Endotracheal Tube Wrongly Placed During Anesthetic Procedure, Surgical Procedure, Unspecified Trial in Daegu (PVC DLT, silicon
Completed
- Endotracheal Tube Wrongly Placed During Anesthetic Procedure
- Surgical Procedure, Unspecified
- PVC DLT
- silicon DLT
-
Daegu, Korea, Republic ofYeungnam University Hospital
Aug 9, 2021
Thoracic Injuries Trial in Winston-Salem (EZ-Blocker, DLT)
Completed
- Thoracic Injuries
- EZ-Blocker
- DLT
-
Winston-Salem, North CarolinaWake Forest Baptist Hospital
Sep 9, 2021
Cost-effectiveness of the Airway Management in Thoracic Surgery
Not yet recruiting
- Brief Description of Focus of Study Instead
- DLT
- (no location specified)
Aug 30, 2021
Basal Cell Carcinoma Trial in Aventura (Placebo-containing MNA, 25 µg doxorubicin-containing MNA, 50 µg doxorubicin-containing
Terminated
- Basal Cell Carcinoma
- Placebo-containing MNA
- +4 more
-
Aventura, FloridaThe Center for Clinical and Cosmetic Research
Aug 16, 2022
Solid Tumor, Adult Trial in Shanghai, Hangzhou (HF1K16 /Arm 45 mg/m2, HF1K16 /Arm 90 mg/m2, HF1K16 /Arm 120 mg/m2)
Recruiting
- Solid Tumor, Adult
- HF1K16 /Arm 45 mg/m2
- +3 more
-
Shanghai, Shanghai, China
- +2 more
May 23, 2022
Breast Cancer Related Lymphoedema Trial in Norwich (Decongestive lymphatic therapy (DLT), Standard Care)
Completed
- Breast Cancer Related Lymphoedema
- Decongestive lymphatic therapy (DLT)
- Standard Care
-
Norwich, Norfolk, United KingdomNorfolk and Norwich University Hospitals NHS Foundation Trust
Oct 6, 2020
Single Lung Ventilation, Thoracic Surgery, Anesthesia Trial in Odense (VivaSight double-lumen tube for single-lung ventilation,
Completed
- Single Lung Ventilation
- +3 more
- VivaSight double-lumen tube for single-lung ventilation
- Conventional double-lument tube for single-lung ventilation
-
Odense, DenmarkOdense University Hospital
Feb 3, 2020
Lung Cancer, Lung Diseases, Tracheal Intubation Morbidity Trial (3D reconstruction automatic matching system, traditional method
Not yet recruiting
- Lung Cancer
- +4 more
- 3D reconstruction automatic matching system
- traditional method for selecting double lumen tube
- (no location specified)
Jun 2, 2023
Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal
Not yet recruiting
- Esophagus Cancer
- +4 more
- Intravenous injection of P-IL-2
- P-IL-2 plus Anti-PD-1 Monoclonal Antibody
- (no location specified)
Apr 24, 2023
Bronchial Hemorrhage Trial (Inflating air into the bronchial cuff before changing position, Inflating air into the bronchial
Not yet recruiting
- Bronchial Hemorrhage
- Inflating air into the bronchial cuff before changing position
- Inflating air into the bronchial cuff after changing position
- (no location specified)
Jun 9, 2022
Non-hodgkin's Lymphoma Trial in Beijing (GNC-038)
Recruiting
- Non-hodgkin's Lymphoma
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 12, 2023
Advanced Malignant Solid Tumors Trial (JCXH-212 Injection)
Not yet recruiting
- Advanced Malignant Solid Tumors
- JCXH-212 Injection
- (no location specified)
Oct 11, 2022
Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)
Recruiting
- Advanced Solid Tumor
- +8 more
- CNSI-Fe(II) 30 mg
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Sep 15, 2023
HER2-positive Breast Cancer Trial in Chengdu (Recombinant anti-HER2 humanized mAb conjugate for injection.R&D code: B003.)
Active, not recruiting
- HER2-positive Breast Cancer
- Recombinant anti-HER2 humanized monoclonal antibody conjugate for injection.R&D code: B003.
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Jan 30, 2023
Multiple Myeloma Trial in Beijing (melphalan HCl for injection)
Recruiting
- Multiple Myeloma
- melphalan hydrochloride for injection
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 26, 2022
Cancer, Gastro-Intestinal Intraepithelial Neoplasia Trial in Jerusalem (Promitil)
Active, not recruiting
- Cancer
- Gastro-Intestinal Intraepithelial Neoplasia
-
Jerusalem, IsraelShaare Zedek Medical Center
Dec 21, 2022
Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)
Not yet recruiting
- Non-hodgkin's Lymphoma
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 27, 2023
Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- (no location specified)
Aug 1, 2023
NK/T Cell Lymphoma, Vascular Immunomother T Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Guangzhou (GNC-038)
Not yet recruiting
- NK/T Cell Lymphoma
- +2 more
-
Guangzhou, Guangdong, China
- +1 more
Jan 12, 2023
Lung Tumors, Pneumothorax Trial (HFNO)
Not yet recruiting
- Lung Neoplasms
- Pneumothorax
- HFNO
- (no location specified)
Dec 23, 2022
Primary Malignant Brain Tumor Trial in China (ABM-1310)
Not yet recruiting
- Primary Malignant Brain Tumor
-
Beijing, Beijing, China
- +3 more
May 28, 2023
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Trial in China (BL-M11D1)
Not yet recruiting
- Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
-
Hefei, Anhui, China
- +7 more
Jun 27, 2023
Anesthesia, Tracheal Intubation, Thoracic Surgery Trial (Changes in intubation position)
Not yet recruiting
- Anesthesia
- +2 more
- Changes in intubation position
- (no location specified)
Jul 29, 2022